Julie Rubinstein sold $709K of ADPT stock

Julie Rubinstein, President and COO of Adaptive Biotechnologies Corp (ADPT), sold 23,762 shares of ADPT stock worth $709K, per an SEC Form 4 filed Nov 11, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Nov 9, 2026, 2 days before it was made public.

ADPT has moved -4.0% since the trade date, from $30.26 to $29.04 (Nov 13, 2026 close).